L Y Herring1,2, C Stevinson1, P Carter3,4, S J H Biddle5, D Bowrey2, C Sutton2, M J Davies4. 1. School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK. 2. University Hospitals of Leicester NHS Trust, Leicester General Hospital, Leicester, UK. 3. Behaviour and Health Research Unit, University of Cambridge, Cambridge, UK. 4. The University of Leicester, Diabetes Research Centre, Leicester, UK. 5. Institute of Sport, Exercise and Active Living, Victoria University, Melbourne, VIC, Australia.
Abstract
BACKGROUND:Bariatric surgery is effective for the treatment of stage II and III obesity and its related diseases, although increasing evidence is showing weight regain ~12-24 months postsurgery. Weight regain increases the risk of physical function decline, which negatively affects an individual's ability to undertake activities of daily living. The study assessed the effects of a 12-week supervised exercise intervention on physical function and body composition in patients between 12 and 24 months post bariatric surgery. METHODS:Twenty-four inactive adult bariatric surgery patients whose body mass index remained ⩾30 kg m2 12 to 24 months post surgery were randomised to an exercise intervention (n=12) or control group (n=12). Supervised exercise consisted of three 60-min gym sessions per week of moderate intensity aerobic and resistance training for 12 weeks. Control participants received usual care. The incremental shuttle walk test (ISWT) was used to assess functional walking performance after the 12-week exercise intervention, and at 24 weeks follow-up. Measures of anthropometric, physical activity, cardiovascular and psychological outcomes were also examined. Using an intention-to-treat protocol, independent t-tests were used to compare outcome measures between groups. RESULTS: Significant improvements in the exercise group were observed for the ISWT, body composition, physical function, cardiovascular and self-efficacy measures from baseline to 12 weeks. A large baseline to 12-week change was observed for the ISWT (exercise: 325.00±117.28 m; control: 355.00±80.62 m, P<0.001). The exercise group at 24 weeks recorded an overall mean improvement of 143.3±86.6 m and the control group recorded a reduction of -32.50±75.93 m. Findings show a 5.6 kg difference between groups in body mass change from baseline to 24 weeks favouring the exercise group. CONCLUSIONS: A 12-week supervised exercise intervention led to significant improvements in body mass and functional walking ability post intervention, with further improvements at the 24-week follow-up.
RCT Entities:
BACKGROUND: Bariatric surgery is effective for the treatment of stage II and III obesity and its related diseases, although increasing evidence is showing weight regain ~12-24 months postsurgery. Weight regain increases the risk of physical function decline, which negatively affects an individual's ability to undertake activities of daily living. The study assessed the effects of a 12-week supervised exercise intervention on physical function and body composition in patients between 12 and 24 months post bariatric surgery. METHODS: Twenty-four inactive adult bariatric surgery patients whose body mass index remained ⩾30 kg m2 12 to 24 months post surgery were randomised to an exercise intervention (n=12) or control group (n=12). Supervised exercise consisted of three 60-min gym sessions per week of moderate intensity aerobic and resistance training for 12 weeks. Control participants received usual care. The incremental shuttle walk test (ISWT) was used to assess functional walking performance after the 12-week exercise intervention, and at 24 weeks follow-up. Measures of anthropometric, physical activity, cardiovascular and psychological outcomes were also examined. Using an intention-to-treat protocol, independent t-tests were used to compare outcome measures between groups. RESULTS: Significant improvements in the exercise group were observed for the ISWT, body composition, physical function, cardiovascular and self-efficacy measures from baseline to 12 weeks. A large baseline to 12-week change was observed for the ISWT (exercise: 325.00±117.28 m; control: 355.00±80.62 m, P<0.001). The exercise group at 24 weeks recorded an overall mean improvement of 143.3±86.6 m and the control group recorded a reduction of -32.50±75.93 m. Findings show a 5.6 kg difference between groups in body mass change from baseline to 24 weeks favouring the exercise group. CONCLUSIONS: A 12-week supervised exercise intervention led to significant improvements in body mass and functional walking ability post intervention, with further improvements at the 24-week follow-up.
Authors: Dale S Bond; Ronald K Evans; Eric DeMaria; Luke Wolfe; Jill Meador; John Kellum; James Maher; Beverly J Warren Journal: Am J Health Behav Date: 2006 Jul-Aug
Authors: Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel Journal: N Engl J Med Date: 2004-12-23 Impact factor: 91.245
Authors: Paul M Coen; Charles J Tanner; Nicole L Helbling; Gabriel S Dubis; Kazanna C Hames; Hui Xie; George M Eid; Maja Stefanovic-Racic; Frederico G S Toledo; John M Jakicic; Joseph A Houmard; Bret H Goodpaster Journal: J Clin Invest Date: 2014-12-01 Impact factor: 14.808
Authors: Charlotte Røn Stolberg; Lene Hymøller Mundbjerg; Else-Marie Bladbjerg; Peter Funch-Jensen; Bibi Gram; Claus Bogh Juhl Journal: Qual Life Res Date: 2018-07-25 Impact factor: 4.147
Authors: Jing-Sheng Li; Tsung-Yuan Tsai; Margaret M Clancy; Guoan Li; Cara L Lewis; David T Felson Journal: Gait Posture Date: 2018-12-24 Impact factor: 2.840
Authors: Alejandro Carretero-Ruiz; María Del Carmen Olvera-Porcel; Iván Cavero-Redondo; Celia Álvarez-Bueno; Vicente Martínez-Vizcaíno; Manuel Ferrer-Márquez; Alberto Soriano-Maldonado; Enrique G Arter Journal: Obes Surg Date: 2019-10 Impact factor: 4.129
Authors: Sofie Possmark; Fanny Sellberg; Ata Ghaderi; Per Tynelius; Mikaela Willmer; Finn Rasmussen; Margareta Persson; Daniel Berglind Journal: PLoS One Date: 2021-11-04 Impact factor: 3.240
Authors: Nawfal W Istfan; Marine Lipartia; Wendy A Anderson; Donald T Hess; Caroline M Apovian Journal: J Clin Endocrinol Metab Date: 2021-01-01 Impact factor: 5.958